Pharmacodynamic study of (131)I-labeled CA215 antibody on an animal model of estrogen-resistant OC-3-VGH ovarian cancer.
about
Pharmacodynamic study of (131)I-labeled CA215 antibody on an animal model of estrogen-resistant OC-3-VGH ovarian cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pharmacodynamic study of (131) ...... stant OC-3-VGH ovarian cancer.
@ast
Pharmacodynamic study of (131) ...... stant OC-3-VGH ovarian cancer.
@en
type
label
Pharmacodynamic study of (131) ...... stant OC-3-VGH ovarian cancer.
@ast
Pharmacodynamic study of (131) ...... stant OC-3-VGH ovarian cancer.
@en
prefLabel
Pharmacodynamic study of (131) ...... stant OC-3-VGH ovarian cancer.
@ast
Pharmacodynamic study of (131) ...... stant OC-3-VGH ovarian cancer.
@en
P2093
P2860
P356
P1476
Pharmacodynamic study of (131) ...... stant OC-3-VGH ovarian cancer.
@en
P2093
Chen-Jing Xie
Jian-Yan Yan
Xiang-Yun Liu
Zu-Yue Sun
P2860
P304
P356
10.3892/ETM.2015.2517
P577
2015-05-26T00:00:00Z